☰

Ai-Xue Liu - Publications

Affiliations: 
Clinical Safety & Risk Management Merck, Semoy, Centre-Val de Loire, France 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Liu AX, Zhang D, Zhu YM, Gao HJ, Jiang JY, Hu XL, Lv PP, Leung PC, Huang HF. Impact of axis of GHRH and GHRH receptor on cell viability and apoptosis of the placental choriocarcinoma cell line. Current Molecular Medicine. PMID 26917260  0.33
2012 Gao HJ, Zhu YM, He WH, Liu AX, Dong MY, Jin M, Sheng JZ, Huang HF. Endoplasmic reticulum stress induced by oxidative stress in decidual cells: A possible mechanism of early pregnancy loss Molecular Biology Reports. 39: 9179-9186. PMID 22733488 DOI: 10.1007/s11033-012-1790-x  0.353
2011 Zou LB, Zhang RJ, Tan YJ, Ding GL, Shi S, Zhang D, He RH, Liu AX, Wang TT, Leung PC, Sheng JZ, Huang HF. Identification of estrogen response element in the aquaporin-2 gene that mediates estrogen-induced cell migration and invasion in human endometrial carcinoma. The Journal of Clinical Endocrinology and Metabolism. 96: E1399-408. PMID 21715543 DOI: 10.1210/jc.2011-0426  0.304
2011 Chan G, Cheung LS, Yang W, Milyavsky M, Sanders AD, Gu S, Hong WX, Liu AX, Wang X, Barbara M, Sharma T, Gavin J, Kutok JL, Iscove NN, Shannon KM, et al. Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood. 117: 4253-61. PMID 21398220 DOI: 10.1182/Blood-2010-11-319517  0.37
2003 Kamasani U, Liu AX, Prendergast GC. Genetic response to farnesyltransferase inhibitors: proapoptotic targets of RhoB. Cancer Biology & Therapy. 2: 273-80. PMID 12878865 DOI: 10.4161/Cbt.2.3.385  0.545
2003 DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. Oncogene. 22: 3578-88. PMID 12789266 DOI: 10.1038/Sj.Onc.1206481  0.588
2001 Liu AX, Rane N, Liu JP, Prendergast GC. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Molecular and Cellular Biology. 21: 6906-12. PMID 11564874 DOI: 10.1128/Mcb.21.20.6906-6912.2001  0.543
2000 Liu A, Prendergast GC. Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors. Febs Letters. 481: 205-8. PMID 11007964 DOI: 10.1016/S0014-5793(00)02003-2  0.519
2000 Liu Ax, Du W, Liu JP, Jessell TM, Prendergast GC. RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Molecular and Cellular Biology. 20: 6105-13. PMID 10913192 DOI: 10.1128/Mcb.20.16.6105-6113.2000  0.578
1998 Liu AX, Testa JR, Hamilton TC, Jove R, Nicosia SV, Cheng JQ. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Research. 58: 2973-7. PMID 9679957  0.339
Show low-probability matches.